Viking Therapeutics Inc

Viking Therapeutics Inc. has experienced a significant decline in stock performance, with a 34% drop over the year, amidst challenging market conditions and analyst skepticism.

Viking Therapeutics, a biotech company, is navigating market challenges while remaining committed to developing innovative therapeutics for metabolic and endocrine disorders.